StoryFunding
Alibaba leads 500 million yuan strategic funding round for StairMed's BCI platform
StairMedImplanted BCI (Ultra-flexible Electrodes)
StairMed closed a 500 million yuan ($73 million) strategic funding round led by Alibaba, with participation from Tencent, Fountainbridge Capital, OrbiMed and other existing shareholders. The round brings total funding since February 2025 to over 860 million yuan, supporting multi-centre clinical trial expansion and commercial pathway development.